According to Sarepta Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 13.71%. At the end of 2024 the company had an Operating Margin of 14.68%.
Year | Operating Margin | Change |
---|---|---|
2024 | 14.68% | -136.64% |
2023 | -40.06% | -41.3% |
2022 | -68.24% | 34.77% |
2021 | -50.64% | -44.54% |
2020 | -91.30% | -49.11% |
2019 | -179.40% | 64.2% |
2018 | -109.26% | 294.36% |
2017 | -27.70% | -99.43% |
2016 | -4,895.28% | -71.95% |
2015 | -17,451.32% | 1172.69% |
2014 | -1,371.21% | 115.95% |
2013 | -634.95% | 697.97% |
2012 | -79.57% | 4.07% |
2011 | -76.46% | 7.45% |
2010 | -71.16% | -19.31% |
2009 | -88.18% | 6.86% |
2008 | -82.52% | -72.62% |
2007 | -301.38% | -98.95% |
2006 | -28,608.52% | 7713.06% |
2005 | -366.16% | -93.71% |
2004 | -5,817.95% | 198.97% |
2003 | -1,945.99% | -35.74% |
2002 | -3,028.39% | 38.83% |
2001 | -2,181.36% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.